Aptose biosciences inc. (APTO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17Jun'17
Cash flows from/(used in) operating activities:
Net loss for the period

-32,297

-26,277

-24,829

-23,516

-27,560

-28,868

0

0

0

-

-

Items not involving cash:
Stock-based compensation

6,035

2,296

2,315

2,763

2,710

4,276

0

0

0

-

-

Shares issued to Aspire Capital as commitment fees

-

-

-

0

-

-

-

0

-

-

-

Depreciation and amortization

164

152

138

134

100

87

0

0

0

-

-

Amortization of right-of-use assets

452

461

0

0

0

-

-

-

-

-

-

Interest on lease liabilities

84

90

0

0

0

-

-

-

-

-

-

Unrealized foreign exchange (gain)/loss

36

23

-26

0

3

-25

0

0

0

-

-

Accrued interest on investments

0

-

0

0

-

-

-

-

-

-

-

Change in operating working capital:
Prepaid expenses

347

379

-35

334

290

324

0

0

0

-

-

Other assets

22

40

-30

-37

-2

27

0

0

0

-

-

Operating lease payments

503

471

0

0

0

-

-

-

-

-

-

Accounts payable

847

645

-13

94

808

726

0

0

0

-

-

Accrued liabilities

562

1,662

1,116

309

-443

298

0

0

0

-

-

Cash used in operating activities

-24,795

-21,558

-20,829

-20,113

-24,027

-23,207

0

0

0

-

-

Cash flows from financing activities:
Offering costs paid

-

-

-

0

-

15

0

0

0

-

-

Issuance of common shares under exercise of stock options

0

-

0

0

-

-

-

0

-

-

-

Cash provided by financing activities

97,706

103,448

35,647

37,238

25,194

27,871

0

0

0

-

-

Cash flows from/(used in) investing activities:
Acquisition of investments, net

0

-

0

0

-

-

-

0

-

-

-

Purchase of property and equipment

94

102

269

255

329

329

0

0

0

-

-

Cash used in investing activities

-29,773

-17,370

-9,178

-8,164

12

12

0

0

0

-

-

Effect of exchange rate fluctuations on cash and cash equivalents held

35

23

0

0

0

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

43,173

64,543

5,630

8,954

1,173

4,668

0

0

0

-

-

Net loss for the period

-

-

-

-

-

-

0

-

-

0

0

Stock-based compensation

-

-

-

-

-

-

0

-

-

0

0

Shares issued to Aspire Capital as commitment fees (note 6(a)(iii))

-

-

-

-

-

-

0

-

-

0

0

Depreciation and amortization

-

-

-

-

-

-

0

-

-

0

0

Interest income

-

-

-

-

-

-

0

-

-

0

0

Unrealized foreign exchange (loss) gain

-

-

-

-

-

-

0

-

-

0

0

Change in non-cash operating working capital (note 8)

-

-

-

-

-

-

0

-

-

0

0

Cash used in operating activities

-

-

-

-

-

-

0

-

-

0

0

Issuance of common shares under the 2018 ATM, net of issuance costs (note 6(a)(i))

-

-

-

-

-

-

0

-

-

0

0

Issuance of common shares under Share Purchase Agreement (note 6(a)(ii))

-

-

-

-

-

-

0

-

-

0

0

Issuance of common shares under the ATM, net of issuance costs (note 6(a)(iv))

-

-

-

-

-

-

0

-

-

0

0

Issuance of common shares upon exercise of stock options (note 7)

-

-

-

-

-

-

0

-

-

0

0

Cash provided by financing activities

-

-

-

-

-

-

0

-

-

0

0

Maturity (acquisition) of investments

-

-

-

-

-

-

0

-

-

0

0

Purchase of property and equipment

-

-

-

-

-

-

0

-

-

0

0

Interest received

-

-

-

-

-

-

0

-

-

0

0

Cash provided by (used in) investing activities

-

-

-

-

-

-

0

-

-

0

0

Effect of exchange rate fluctuations on cash and cash equivalents held

-

-

-

-

-

-

0

-

-

0

0

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

0

-

-

0

0

The 2018 Purchase Agreement [Member]
Issuance of common shares

-

-

-

0

-

-

-

-

-

-

-

The 2017 Purchase Agreement [Member]
Issuance of common shares

-

-

-

-

-

-

0

0

0

-

-

The 2018 ATM Offering [Member]
Issuance of common shares

-

-

-

-

-

-

-

0

-

-

-

Issuance of common shares

-

178

0

0

0

-

-

-

-

-

-

The 2019 Share Purchase Agreement [Member]
Issuance of common shares

-

-

-

-

0

-

-

-

-

-

-

Public Offering [Member]
Proceeds from Issuance of Common Stock

-

-

-

0

-

-

-

-

-

-

-